Ukrainian citizen sentenced to community service for wearing St. George ribbonSociety & Culture July 25, 11:04
Top official comments on complications following Siemens refusal to work with state firmsBusiness & Economy July 25, 10:35
Russian-Syrian checkpoint opens in Eastern Goutha de-escalation zoneWorld July 25, 8:17
Russian-Chinese naval drills in Baltic Sea to enter active phaseMilitary & Defense July 25, 7:59
Putin to meet with Iraq’s vice-presidentRussian Politics & Diplomacy July 25, 6:49
Russian super-heavy booster vehicle to bring payloads of 70 tns to orbitScience & Space July 25, 5:34
New limits on microloans to kill off most micro lenders in Russia, say expertsBusiness & Economy July 25, 3:45
Lavrov says astonished by mass hysteria among US politiciansRussian Politics & Diplomacy July 25, 1:35
Lavrov comments on Syrian de-escalation zone agreementRussian Politics & Diplomacy July 24, 20:15
MOSCOW, November 21. /ITAR-TASS/. The Russian Health Ministry has expressed concern over a big number of pharmacies in Russia, which provokes price dumping policies and lowers pharmacy quality standards, Health Minister Veronika Skvortsova told the Presidium of the Russian government on Thursday.
The Russian pharmacy market has a huge number of economic entities running the production and distribution sectors. A total of 550 organizations and a thousand foreign pharmacies have licenses for medicine production and deliveries, Skvortsova said with reference to the Single License Register of the Russian Ministry of Industry and Trade.
In Russia, there is one pharmacy per every 1,450 people, in the United States - one pharmacy per every 4,500 people and in Germany - one pharmacy per 3,900 people, she said. There is a surplus number of pharmacies in Russia; the quality of pharmacy services is worsening; the share of pharmacies capable to produce medicines or which have the necessary conditions for the storage of medicines and narcotic-containing stuff has been declining, Skvortsova said.
Creation of vertically integrated structures and large pharmacy networks hinders the development of a competitive environment, provokes price dumping and creates problems for producers of medicines, Skvortsova said.